This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Thomas Jefferson University. Active years: 1995-2000.
Company Filing History:
Years Active: 1995-2000
Title: Mark Feitelson: Innovator in Hepatitis Research
Introduction
Mark Feitelson is a distinguished inventor based in North Wales, PA (US). He has made significant contributions to the field of hepatitis research, holding a total of 2 patents. His work focuses on the development of transgenic animals and methods for detecting hepatitis B variants.
Latest Patents
Feitelson's latest patents include innovative approaches to studying hepatitis viruses. One of his patents involves transgenic animals capable of replicating hepatitis viruses, which are essential for evaluating virus-chemical and virus-drug interactions in chronic hepatitis infections. Another notable patent provides methods for detecting hepatitis B variants that have deletions within the X gene. This invention allows for the simultaneous detection of antibodies against the X and polymerase gene products of HBV, facilitating the identification of atypical infections through a polymerase chain reaction (PCR) assay.
Career Highlights
Mark Feitelson is affiliated with Thomas Jefferson University, where he continues to advance research in hepatitis. His work has been instrumental in enhancing the understanding of hepatitis infections and developing methods for their detection and treatment.
Collaborations
Feitelson has collaborated with notable colleagues, including Ling-Xun Duan and Jianhui Guo, contributing to the advancement of hepatitis research through teamwork and shared expertise.
Conclusion
Mark Feitelson's innovative work in hepatitis research has led to significant advancements in the field. His patents and collaborations reflect his commitment to improving detection methods and understanding of hepatitis viruses.